Brian is a Business Development Director covering Covance’s Early Development in Germany, Austria, Hungary and Poland. He harnesses Covance’s people, capabilities and experience to mentor and advise pharmaceutical and biotechnology companies in their early stages to the first-in-human and first-in-patient milestones.
Brian received his Bachelor of Science in Biochemistry and Cell Biology from the University of California, San Diego; an ADME Toxicology Certificate from UC San Diego Extension; and his PhD in Healthcare Innovation from the University of Wales through the Prince of Wales Innovation Scholarship. He has worked in a range of R&D and commercial positions at Favrille, Scripps Research Institute, Ionis Pharmaceuticals, Amylin Pharmaceuticals, Allerna Therapeutics, Celixir PLC, and Swansea University’s Heath Informatics Research Unit. He also has a range of publications and patents in a range of technologies (cellular therapies, growth factors, antisense, carbon nanostructures) and applications (neuroscience, tissue engineering/regeneration, cardiovascular, oncology, innovation, etc).